Regenicin, Inc.

RGIN · OTC
Analyze with AI
9/30/2022
9/30/2021
9/30/2020
9/30/2019
Assets
Cash & Equivalents$15$2$1$1
Short-Term Investments$1$3$3$5
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$0$0$0$0
Total Curr. Assets$15$5$4$5
Property Plant & Equip (Net)$0$0$0$0
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0-$3$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$0
Total NC Assets$0$0-$3$0
Other Assets$0$0$3$0
Total Assets$15$5$4$5
Liabilities
Payables$103$94$89$138
Short-Term Debt$643$603$578$455
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$4,867$4,266$3,624$3,140
Total Curr. Liab.$5,613$4,962$4,291$3,733
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$0$0$0$0
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$5,613$5,169$4,291$3,733
Equity
Pref Stock$1$1$1$1
Common Stock$158$158$158$158
Retained Earnings-$15,960-$15,527-$14,650-$14,090
AOCI$0$0$0-$0
Other Equity$10,204$10,204$10,204$10,204
Total Equity-$5,597-$5,164-$4,287-$3,728
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$15$5$4$5
Net Debt$628$601$577$454